Allergan, Asterand in ophthalmic deal

Asterand (LSE:ATD) granted Allergan (NYSE:AGN) exclusive, worldwide rights to develop and commercialize undisclosed, preclinical small moleculeprostaglandinreceptor agonists for ophthalmic indications...